Previously NewsNews home
Matt Hagen in Clayface (2026), the DC Studios body-horror film starring Tom Rhys Harries
Photo: DC Studios / Warner Bros. Pictures
MOVIE OF THE WEEK

'Clayface' Review: DC's Body-Horror Gamble Mostly Pays Off

DC Studios' third film is not a superhero romp at all — it is an R-rated body-horror tragedy about a disfigured actor who trades his face for a body made of clay. Tom Rhys Harries and Naomi Ackie carry it, the practical gore earns the rating, and the middle sags. Our honest review.

The Short Version

Advertisement
Share

The Short Version is in the box above. Here is the longer truth: Clayface is the strangest bet DC Studios has made yet — a hard-R body-horror film built around a second-tier Batman villain most moviegoers could not pick out of a lineup — and the bet mostly pays off. It is gruesome, sad, and anchored by a genuine breakout performance. It is also uneven: the middle repeats itself, some of the digital face-work wobbles, and the climax is smaller than the build-up promises. Good, honestly good — just not the masterpiece the earliest reactions were selling.

The Setup

Matt Hagen (Tom Rhys Harries) is a Gotham street kid turned rising Hollywood star, and his face is his whole career — until a local crime boss's men leave him horribly disfigured and his team abandons him. With nothing left, Hagen turns to an experimental treatment from scientist Dr. Caitlyn Bates (Naomi Ackie) that miraculously restores his looks. It also does something else: his body stops holding a fixed shape, his grip on who he is starts to slip, and a man who lived by his face begins a destructive spiral toward revenge. No spoilers past the premise: this is an origin story told as a tragedy, not a hero's journey with the polarity flipped. The character dates to 1940 in the comics, and Hagen's version to 1961 — a lot of fans first met him in Batman: The Animated Series — but the film asks for no homework. Collider's Steven Weintraub made the point plainly after his screening: the movie is fantastic and works with no knowledge of DC at all.

The pedigree behind the camera is the story of the film. James Watkins — Eden Lake, The Woman in Black, the American Speak No Evil — directs from a screenplay by Mike Flanagan (The Haunting of Hill House) and Hossein Amini, from a story by Flanagan. James Gunn and Peter Safran produce for DC Studios alongside Matt Reeves and Lynn Harris. It is DC Studios' third theatrical release, after Superman and Supergirl, and it could not be less like either of them: a reported $44 million budget, an R rating for strong bloody violence, gore, language, some nudity and brief drug use, and a Gotham that Slant Magazine praised for feeling actively malevolent — a city of corruption that seeps into every corner, seen for once from the gutter instead of from Batman's shoulder. Batman, for the record, does not show up.

Advertisement

What Works

Harries, first and most. The whole film rests on a face — losing it, getting it back, watching it stop obeying — and Harries plays every stage of that without hiding behind the prosthetics. Critics who love the movie keep landing on him: the early reactions called him a star in waiting, and the full reviews have kept the praise, crediting his wounded intensity for carrying scenes the makeup alone could not. Ackie matches him as Bates, the scientist whose miracle is also her mistake, and the two of them give the film the gothic-romance pulse that more than one critic has compared to The Fly and Darkman. That is the right company. Like those films, Clayface understands that body horror only hurts when you care about the body.

The horror itself delivers. This is a hard R and it behaves like one: brutal, practical-led transformation work and kills that had preview audiences reacting out loud, per Collider's account of its screening. Watkins builds dread the way he did in Speak No Evil — quiet, held shots, then a chord from Volker Bertelmann's score or a wet, awful sound where a jump scare would be cheaper. Rotten Tomatoes has the film at 76 percent from 116 reviews, comfortably Fresh and well clear of Supergirl's 52 percent, if short of Superman's 83. Slant Magazine called it, as a standalone property, a surprisingly sturdy and compelling horror-thriller. On the evidence of its best stretches — the treatment sequences, the first time Hagen tests what his hands can do — that undersells it slightly.

What Doesn't

The middle. Once the premise is established, the film circles it: Hagen tests his new condition, the story resets, he tests it again, and the beginning of the second act turns repetitive before the final stretch finds its pace again. MovieWeb's Molly Freeman put the harsher version of the case — that the film offers more gross body horror than compelling character study, with only a few redeeming moments — and while that is tougher than the movie deserves, anyone who has sat through the sag will understand where it comes from. The romance at the center is the other soft spot: Harries and Ackie are each excellent, but the turn from doctor-and-patient to something more is asserted more than it is built, and some viewers have flagged the chemistry as the one element that never quite ignites.

The effects are split, too. The practical work is superb; the fully digital facial transformations occasionally look unnatural in a way that breaks the spell for a beat. And the climax — a nightclub confrontation the whole film has been aiming at — lands smaller and flatter than the build-up earns. There are no mid- or post-credits scenes, for anyone already standing up: DC Studios is letting this one end where it ends.

The Verdict

Here is the honest Previously line: Clayface is a good horror film wearing a superhero universe's clothes, and the disguise is the least interesting thing about it. As a DC entry it is a proof of concept — that this universe can hold a small, mean, sad monster movie next to its capes — and as a Friday night in late October it is exactly the right kind of nasty. Horror fans should go. DC completists should go. Anyone squeamish about gore should believe the rating and stay home, because the film does not blink, and neither does its camera.

Previously score: 7.5 out of 10.

How to Watch

Clayface is in theaters now, wide release as of Friday, October 23, 2026, from Warner Bros. Pictures. It is theatrical-only at launch and no streaming or premium-VOD date has been announced yet; we will update this review when Warner Bros. sets one. Tickets are on sale through the usual theater chains and apps.

Running time is 1 hour 48 minutes, rated R for strong bloody violence, gore, language, some nudity and brief drug use. Reported production budget: $44 million. More from the Movies Desk: last week's Street Fighter review, our review of Tyler Perry's Doing Life, and the full archive at Previously Reviews.

Sources · 5 sources
Keep reading

More from the newsroom

All stories →
Law & Order: Special Victims Unit Season 28 key art featuring Captain Olivia Benson and the SVU squadNews
Law & Order: SVU Review: Bruno Pushes to a Breaking Point as Benson Takes On the Feds in 'Anonymity'News· Oct 23, 2026
Virginia state Sen. L. Louise Lucas at the 2008 Democratic National Convention in Denver.News
Louise Lucas Indicted on Federal Marijuana Racketeering ChargesNews· Oct 23, 2026
St. Louis Blues goaltender Joel Hofer (30) receives a tap on the mask from alternate captain Colton Parayko (55) after the Blues' 6-2 win over the Vegas Golden Knights at Enterprise Center in St. Louis on October 22, 2026News
Justin Barron Piles Up Four Points as Blues Rout Golden Knights 6-2 in St. LouisNews· Oct 23, 2026
John Anderson performing on stage with his guitar (2008)News
John Anderson, Country Music Hall of Famer Behind ‘Swingin’’ and ‘Seminole Wind,’ Dies at 71News· Oct 22, 2026
A brightly lit television studio debate stageNews
In Final Michigan Senate Debate, El-Sayed and Rogers Question Each Other’s LoyaltiesNews· Oct 22, 2026
A packed arena crowd under bright lights at a campaign rallyNews
Trump Rally at Clemson Turns Chaotic as Hecklers Are Removed and One Is PunchedNews· Oct 22, 2026